S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

NCT00946712 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1333

Enrollment

NETWORK

Sponsor class

Stopped terminated at pre-planned futility analysis

Conditions

Recurrent Large Cell Lung Carcinoma
Recurrent Lung Adenocarcinoma
Recurrent Squamous Cell Lung Carcinoma
Stage IV Large Cell Lung Carcinoma
Stage IV Lung Adenocarcinoma
Stage IV Squamous Cell Lung Carcinoma

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Carboplatin
BIOLOGICAL: Cetuximab
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]